Generation of Organoids from Mouse Extrahepatic Bile Ducts.
Journal
Journal of visualized experiments : JoVE
ISSN: 1940-087X
Titre abrégé: J Vis Exp
Pays: United States
ID NLM: 101313252
Informations de publication
Date de publication:
23 04 2019
23 04 2019
Historique:
entrez:
14
5
2019
pubmed:
14
5
2019
medline:
19
3
2020
Statut:
epublish
Résumé
Cholangiopathies, which affect extrahepatic bile ducts (EHBDs), include biliary atresia, primary sclerosing cholangitis, and cholangiocarcinoma. They have no effective therapeutic options. Tools to study EHBD are very limited. Our purpose was to develop an organ-specific, versatile, adult stem cell-derived, preclinical cholangiocyte model that can be easily generated from wild type and genetically engineered mice. Thus, we report on the novel technique of developing an EHBD organoid (EHBDO) culture system from adult mouse EHBDs. The model is cost-efficient, able to be readily analyzed, and has multiple downstream applications. Specifically, we describe the methodology of mouse EHBD isolation and single cell dissociation, organoid culture initiation, propagation, and long-term maintenance and storage. This manuscript also describes EHBDO processing for immunohistochemistry, fluorescent microscopy, and mRNA abundance quantitation by real-time quantitative reverse transcription polymerase chain reaction (qRT-PCR). This protocol has significant advantages in addition to producing EHBD-specific organoids. The use of a conditioned medium from L-WRN cells significantly reduces the cost of this model. The use of mouse EHBDs provides almost unlimited tissue for culture generation, unlike human tissue. Generated mouse EHBDOs contain a pure population of epithelial cells with markers of endodermal progenitor and differentiated biliary cells. Cultured organoids maintain homogenous morphology through multiple passages and can be recovered after a long-term storage period in liquid nitrogen. The model allows for the study of biliary progenitor cell proliferation, can be manipulated pharmacologically, and may be generated from genetically engineered mice. Future studies are needed to optimize culture conditions in order to increase plating efficiency, evaluate functional cell maturity, and direct cell differentiation. Development of co-culture models and a more biologically neutral extracellular matrix are also desirable.
Identifiants
pubmed: 31081815
doi: 10.3791/59544
pmc: PMC9067596
mid: NIHMS1798129
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Video-Audio Media
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NIDDK NIH HHS
ID : P01 DK062041
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK034933
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK118563
Pays : United States
Références
Nature. 2013 Feb 14;494(7436):247-50
pubmed: 23354049
Proteomics. 2010 May;10(9):1886-90
pubmed: 20162561
Stem Cell Reports. 2017 Apr 11;8(4):822-830
pubmed: 28344000
Hepatology. 2011 Dec;54(6):2159-72
pubmed: 21809358
Hepatology. 2013 Oct;58(4):1486-1496
pubmed: 23703727
Nat Med. 2017 Aug;23(8):954-963
pubmed: 28671689
Proc Natl Acad Sci U S A. 2017 May 9;114(19):E3806-E3815
pubmed: 28439013
Dig Liver Dis. 2015 Nov;47(11):964-72
pubmed: 26277684
Cell. 2015 Jan 15;160(1-2):299-312
pubmed: 25533785
Lab Invest. 2009 Apr;89(4):456-69
pubmed: 19204666
Lab Invest. 2015 Jun;95(6):684-96
pubmed: 25867762
Mayo Clin Proc. 2015 Jun;90(6):791-800
pubmed: 25957621
Cell Mol Gastroenterol Hepatol. 2017 Nov 28;5(2):159-160
pubmed: 29693042
Compr Physiol. 2013 Jul;3(3):1035-78
pubmed: 23897680
Trends Biotechnol. 2016 Sep;34(9):711-721
pubmed: 27012157
Trends Mol Med. 2017 May;23(5):393-410
pubmed: 28341301
Science. 2018 Mar 9;359(6380):1113
pubmed: 29590038
J Anat. 2012 Feb;220(2):186-99
pubmed: 22136171
Stem Cells Int. 2016;2016:3658013
pubmed: 26880956
Hepatol Commun. 2018 Dec 11;3(2):277-292
pubmed: 30766964
Cell Mol Gastroenterol Hepatol. 2018 May 22;6(3):301-319
pubmed: 30123820